Iros Pharma Private Limited - Company Profile

It is a automotive private limited company based in Vijayawada, Andhra Pradesh, India, established in 2019.
2019 Vijayawada, Andhra Pradesh, India Active
Last Updated:
Access Report
About Iros Pharma Private Limited

Iros Pharma Private Limited, a active private limited company, was established on 16 September 2019 in Vijayawada, Andhra Pradesh, India. Engaging in auto parts & components within the trade sector, it holds CIN: U24299AP2019PTC112905. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Deepa Baddela (Managing Director), Yunus Mohammed Karim (Additional Director). Past directors included Deepa Baddela, Somnath Adduri, Reshma Bhavya Adduri. Its latest AGM occurred on 13 September 2022, with the balance sheet filed on 31 March 2022. It is based at D. No. 4-36-88B, Viswa Brahmin Street, Milk Project,, Vijayawada, Andhra Pradesh, 520001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299AP2019PTC112905

  • Registration Number

    112905

  • Incorporation Date

    16 September 2019

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** 8.67%
  • Profit Growth **** 11.21%
  • Ebitda **** 6.45%
  • Net Worth 15.83%
  • Total Assets **** 11.26%
Company report

Iros Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Iros Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Iros Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepa Baddela Managing Director 25 Jan 2023 Current
Yunus Mohammed Karim Additional Director 18 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 25 Jan 2023 Past
Pramod Abcsdd Director 18 May 2025 Past
Pramod Abcsdd Director 18 May 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Iros Pharma.

Iros Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.67% increase. The company also saw a substantial improvement in profitability, with a 11.21% increase in profit. The company's net worth Soared by an impressive increase of 15.83%.

Iros Pharma revenue growth over time
Iros Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.67%
*******
*******
*******
*******
Revenue from Operations
*******
 8.65%
*******
*******
*******
*******
Total Assets
*******
 11.26%
*******
*******
*******
*******
Profit or Loss
*******
 11.21%
*******
*******
*******
*******
Net Worth
*******
 15.83%
*******
*******
*******
*******
EBITDA
*******
 6.45%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Iros Pharma?

In 2022, Iros Pharma had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Iros Pharma?

Unlock and access historical data on people associated with Iros Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iros Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iros Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Iros Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Yunus Mohammed Karim was appointed as a Additional Director was appointed as a Additional Director on 18 May 2025 & has been associated with this company since 8 months 24 days . was completed.

  • Director Appointment

    Deepa Baddela was appointed as a Managing Director was appointed as a Managing Director on 25 Jan 2023 & has been associated with this company since 3 years 16 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Iros Pharma Private Limited last Annual general meeting of members was held on 13 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Iros Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada. was recorded as a recent event.

  • Company Incorporation

    The activity Iros Pharma Private Limited was registered on 16 Sep 2019 with Roc Vijayawada & aged 6 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Iros Pharma Private Limited?

The CIN of Iros Pharma Private Limited is U24299AP2019PTC112905.

Where is Iros Pharma Private Limited headquartered?

Iros Pharma Private Limited is headquartered at D. No. 4-36-88B, Viswa Brahmin Street, Milk Project,, Vijayawada, Andhra Pradesh, 520001.

When was Iros Pharma Private Limited incorporated?

Iros Pharma Private Limited was incorporated on 16 September 2019.

Who are the current directors of Iros Pharma Private Limited?

The current directors of Iros Pharma Private Limited are

What is the primary industry of Iros Pharma Private Limited?

The primary industry of Iros Pharma Private Limited is Trade.

Is Iros Pharma Private Limited a listed company?

Iros Pharma Private Limited is unlisted.

What is the capital structure of Iros Pharma Private Limited?

The authorized capital of Iros Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available